Posted in | News | Mining Business

Fission Gets Approval from Court for Arrangement Involving the Spin-Out of Fission Spinco

FISSION URANIUM CORP. ("Fission" or the "Company") is pleased to announce that the previously announced plan of arrangement (the "Arrangement") pursuant to which certain assets of Fission will be spun-out to Fission 3.0 Corp. ("Fission Spinco") has been approved by the Court of Queen's Bench of Alberta. On completion of the Arrangement, each Fission shareholder will hold: (i) one new common share of the Company post-Arrangement; and (ii) one common share of Fission Spinco (a "Fission Spinco Share").

The Arrangement is subject to final approval by the TSX Venture Exchange (the "TSX-V"). Completion of the Arrangement is expected to occur on December 6, 2013 and trading of the Fission Spinco Shares is expected to commence on the TSX-V at the open of markets on December 10, 2013.

Dev Randhawa, Chairman and CEO of Fission Uranium, commented,

"I would like to thank our legal team, financial advisors and management for all their hard work in making this come together. It's been an amazing year for the PLS project and I know we are looking forward to an aggressive winter exploration program."

As previously described in Fission's management information circular dated October 29, 2013 (the "Circular"), the TSX-V has determined that its due bill trading procedure will be used in connection with the distribution of the Fission Spinco Shares to the Fission shareholders. Pursuant to these procedures, the Fission Spinco Shares will trade on a "due bill" basis on the TSX-V in the period from December 4, 2013 up to and including December 9, 2013, being the anticipated date on which Fission Spnico Shares will paid out to Fission shareholders (the "Due Bill Period"). Holders of Fission shares on December 6, 2013, including purchasers of Fission shares during the Due Bill Period, will be entitled to receive Fission Spinco Shares. Any trades that are executed during the Due Bill Period will be automatically flagged to ensure that such purchasers receive the entitlement to the Fission Spinco Shares. Sellers of Fission shares during the Due Bill Period will not be entitled to Fission Spinco Shares.

The Fission Spinco Shares will commence trading on the TSX-V on an "ex-distribution" basis at the open of markets on December 10, 2013, as of which date purchasers of Fission shares will no longer have an attaching right to receive Fission Spinco Shares in accordance with the Arrangement. The "due bills" will be redeemed on December 12, 2013, once all trades attached to "due bills" entered into during the Due Bill Period have settled.

The anticipated dates provided above may change for a number of reasons, including inability to secure necessary regulatory or other third party approvals that may be required to satisfy the other conditions to the completion of the Arrangement. Investors are encouraged to consult with their financial advisors regarding the specific implications of buying or selling Fission shares before, on or after the anticipated effective date of the Arrangement.

Additional information regarding the terms of the Arrangement are set out in the Circular, which is available under Fission's profile at

About Fission Uranium Corp.

Fission Energy Corp. is a Canadian based resource company specializing in the strategic acquisition, exploration and development of uranium properties and is headquartered in Kelowna, British Columbia. Common Shares are listed on the TSX Venture Exchange under the symbol "FCU".

Additional information about Fission is available on Fission's website at or under its profile on SEDAR at


Dev Randhawa, Chairman & CEO


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.